Côte d’Ivoire’s public investment fund, CDC-CI Capital, has invested 800 million CFA francs ($1.4 million) in the fintech Julaya. The deal, structured as convertible bonds, was signed on October 17, 2025.
This investment is the latest in a series of operations carried out by the public fund, which is actively deploying capital to support Ivorian tech companies.
The capital injection aims to support the development of Julaya Côte d’Ivoire, financing the necessary investments to expand its service offering. According to the parties involved, this operation will provide Julaya with resources to accelerate its growth strategy and acquire new clients.
This funding comes at a strategic moment for the fintech. In May 2025, Julaya obtained official Payment Establishment approval (n°EP.C1.004/2025) from the Central Bank of West African States (BCEAO). This approval is a crucial regulatory step for payment companies operating in the region.
Founded in 2018 by Mathias Léopoldie and Charles Talbot, Julaya specializes in payment solutions for businesses and claims to have over 1,000 clients, ranging from SMEs to large organizations.
CDC-CI Capital, the investor, is the investment arm of Côte d’Ivoire’s public financial institution, Caisse des Dépôts et Consignations (CDC-CI). The fund is primarily financed by the World Bank through the Competitive Value Chains for Employment and Economic Transformation Project (PCCET).
The Julaya deal is part of a broader investment strategy by CDC-CI Capital to strengthen the local tech ecosystem in 2025.
Earlier in October, the fund announced an equity investment of 350 million CFA francs ($620,500) in Ades, an Ivorian healthtech startup. This funding was intended to modernize Ades’ digital platform, UMED, and expand its physical capabilities, including biomedical equipment and its fleet of vehicles for home visits.
Earlier in the year, CDC-CI Capital also injected 800 million CFA francs ($1.3 million) into the fintech Djamo, a company focused on financial inclusion for underbanked populations.
By supporting two fintechs (Julaya and Djamo) and one healthtech (Ades) with distinct business models in the same year, CDC-CI Capital is positioning itself as a leading local investor. This public support provides growth capital in a market where early-stage financing remains a challenge, while also signaling the government’s confidence in technology to modernize key sectors of the economy.